Usama Gergis
Thomas Jefferson University · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Weill Medical College of Cornell University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Usama Gergis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05031897 · Two Step Haplo With Radiation ConditioningThomas Jefferson University · recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma · principal investigator
- Ph2NCT03712878 · 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- Ph2NCT03032783 · A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicitySidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- Ph2NCT02566304 · Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Aplastic Anemia · principal investigator
- Ph2NCT01757197 · Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)Weill Medical College of Cornell University · terminated · Glucocorticosteroid Refractory Acute GVHD · principal investigator
- Ph2NCT01384513 · A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities · principal investigator
- Ph1NCT00875693 · A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)Weill Medical College of Cornell University · completed · Acute Myelogenous Leukemia, Myelodysplastic Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:50 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- 296 citationsRCR 10.5
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.Biol Blood Marrow Transplant · 2016113 citationsRCR 4.4
- 106 citationsRCR 2.4
- 51 citationsRCR 4.9
- Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.Biol Blood Marrow Transplant · 201947 citationsRCR 2.2
- Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant · 201942 citationsRCR 1.9
- Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.Haematologica · 201633 citationsRCR 1.2
- Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.Blood Adv · 201933 citationsRCR 1.4
- A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.Biol Blood Marrow Transplant · 201328 citationsRCR 0.7
- Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.Biol Blood Marrow Transplant · 201925 citationsRCR 1.5